Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4X80

Crystal Structure of murine 7B4 Fab monoclonal antibody against ADAMTS5

Summary for 4X80
Entry DOI10.2210/pdb4x80/pdb
Related4X8J
DescriptorIgG1 7B4 FAB Light Chain, IgG1 7B4 FAB Heavy chain (3 entities in total)
Functional Keywordsmonoclonal, immune system
Biological sourceMus musculus
More
Total number of polymer chains2
Total formula weight47693.81
Authors
Larkin, J.,Lohr, T.A.,Elefante, L.,Shearin, J.,Matico, R.,Su, J.-L.,Xue, Y.,Liu, F.,Genell, C.,Miller, R.E.,Tran, P.B.,Malfait, A.-M.,Maier, C.C.,Matheny, C.J. (deposition date: 2014-12-09, release date: 2015-04-08, Last modification date: 2024-11-06)
Primary citationLarkin, J.,Lohr, T.A.,Elefante, L.,Shearin, J.,Matico, R.,Su, J.L.,Xue, Y.,Liu, F.,Genell, C.,Miller, R.E.,Tran, P.B.,Malfait, A.M.,Maier, C.C.,Matheny, C.J.
Translational development of an ADAMTS-5 antibody for osteoarthritis disease modification.
Osteoarthr. Cartil., 23:1254-1266, 2015
Cited by
PubMed Abstract: Aggrecanase activity, most notably ADAMTS-5, is implicated in pathogenic cartilage degradation. Selective monoclonal antibodies (mAbs) to both ADAMTS-5 and ADAMTS-4 were generated and in vitro, ex vivo and in vivo systems were utilized to assess target engagement, aggrecanase inhibition and modulation of disease-related endpoints with the intent of selecting a candidate for clinical development in osteoarthritis (OA).
PubMed: 25800415
DOI: 10.1016/j.joca.2015.02.778
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.6 Å)
Structure validation

231029

건을2025-02-05부터공개중

PDB statisticsPDBj update infoContact PDBjnumon